Jefferies Financial Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-45,200
| Closed | -$4M | – | 1046 |
|
|
2025
Q1 | $4M | Sell |
45,200
-2,300
| -5% | -$204K | 0.04% | 268 |
|
|
2024
Q4 | $4.14M | Sell |
47,500
-2,023
| -4% | -$176K | 0.02% | 316 |
|
|
2024
Q3 | $4.58M | Buy |
49,523
+47,017
| +1,876% | +$4.35M | 0.03% | 225 |
|
|
2024
Q2 | $270K | Sell |
2,506
-82
| -3% | -$8.84K | ﹤0.01% | 893 |
|
|
2024
Q1 | $245K | Sell |
2,588
-14,294
| -85% | -$1.36M | ﹤0.01% | 971 |
|
|
2023
Q4 | $1.56M | Buy |
16,882
+4,355
| +35% | +$402K | 0.01% | 526 |
|
|
2023
Q3 | $629K | Buy |
12,527
+5,280
| +73% | +$265K | 0.01% | 642 |
|
|
2023
Q2 | $458K | Buy |
7,247
+1,432
| +25% | +$90.5K | ﹤0.01% | 805 |
|
|
2023
Q1 | $262K | Buy |
5,815
+337
| +6% | +$15.2K | ﹤0.01% | 867 |
|
|
2022
Q4 | $240K | Buy |
+5,478
| New | +$240K | ﹤0.01% | 813 |
|